Extensive Drug Resistance of Strong Biofilm-Producing Acinetobacter baumannii Strains Isolated from Infections and Colonization Hospitalized Patients in Southern Poland.
Tomasz KasperskiDorota RomaniszynEstera Jachowicz-MatczakMonika Pomorska-WesołowskaJadwiga Wójkowska-MachAgnieszka ChmielarczykPublished in: Pathogens (Basel, Switzerland) (2023)
Acinetobacter baumannii (AB) is a bacterium that causes infections, particularly in immunocompromised patients. Treatment is challenging due to biofilm formation by AB strains, which hinders antibiotic effectiveness and promotes drug resistance. The aim of our study was to analyze the biofilm-producing capacity of AB isolates from various forms of infections in relation to biofilm-related genes and their drug resistance. We tested one hundred isolates for biofilm formation using the crystal violet microplate method. Drug resistance analyses were performed based on EUCAST and CLSI guidelines, and biofilm genes were detected using PCR. All tested strains were found to form biofilms, with 50% being ICU strains and 72% classified as strong biofilm producers. Among these, 87% were extensively drug-resistant (XDR) and 2% were extra-extensively drug-resistant (E-XDR). The most common gene set was bap , bfm S, csu E, and omp A, found in 57% of all isolates. Our research shows that, regardless of the form of infection, biofilm-forming strains can be expected among AB isolates. The emergence of E-XDR and XDR strains among non-ICU infections highlights the necessity for the rational use of antibiotics to stop or limit the further acquisition of drug resistance by A. baumannii .
Keyphrases
- drug resistant
- biofilm formation
- acinetobacter baumannii
- multidrug resistant
- pseudomonas aeruginosa
- escherichia coli
- candida albicans
- staphylococcus aureus
- cystic fibrosis
- intensive care unit
- randomized controlled trial
- end stage renal disease
- genome wide
- ejection fraction
- genetic diversity
- dna methylation
- prognostic factors
- peritoneal dialysis
- transcription factor
- clinical practice
- systematic review
- chronic kidney disease
- patient reported
- solid state